CN108456264A - A kind of purification process for the more glucose sodium that relaxes - Google Patents

A kind of purification process for the more glucose sodium that relaxes Download PDF

Info

Publication number
CN108456264A
CN108456264A CN201810153493.0A CN201810153493A CN108456264A CN 108456264 A CN108456264 A CN 108456264A CN 201810153493 A CN201810153493 A CN 201810153493A CN 108456264 A CN108456264 A CN 108456264A
Authority
CN
China
Prior art keywords
purification process
glucose sodium
acid
sodium
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810153493.0A
Other languages
Chinese (zh)
Other versions
CN108456264B (en
Inventor
梅杰
姜立志
周大勇
田伟伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hengrui Medicine Co Ltd
Original Assignee
Jiangsu Hengrui Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co Ltd filed Critical Jiangsu Hengrui Medicine Co Ltd
Publication of CN108456264A publication Critical patent/CN108456264A/en
Application granted granted Critical
Publication of CN108456264B publication Critical patent/CN108456264B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Sustainable Development (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

The present invention provides a kind of purification process for the more glucose sodium that relaxes.Specifically, the purification process includes:By easypro more glucose sodium crude product loading to using silica gel C18 to be purified on the chromatographic column of filler, obtains easypro more glucose purity and be more than 99%.The method of the invention not only can guarantee the quality of product, and be suitable for technique amplification production.

Description

A kind of purification process for the more glucose sodium that relaxes
Technical field
The present invention relates to a kind of purification process for the more glucose sodium that relaxes, specifically, utilizing the chromatographic column that silica gel C18 is filler It purifies and the crude product for the more glucose sodium that relaxes is isolated and purified, to obtain the easypro more glucose sodium of high-purity.
Background technology
The more glucose sodium that relaxes is a kind of derivative of gamma-cyclodextrin, and molecule is made of lipophilic core and hydrophilic outer end, is one The selective muscle relaxant antagonistic of kind, chemical name:Complete (2- carboxy ethyls) the thio-y-cvclodextrin sodium salts of the full deoxidation -6- of 6- (eight sodium salts), structural formula is as follows:
More glucose sodium relax for reversing conventional use of neuromuscular blocking drug rocuronium or Vecuronium Bromide to act on, can stand Reverse used rocuronium effect of being grown up, conventional reverse Children and teenager (2~17 years old) used rocuronium Effect.The more glucose sodium that relaxes is first and unique selectivity relaxation bonding agent, is the great medicine in first, arcotic field over 20 years Object is in progress, and is known as landmark flesh pine antagonist, granted in U.S.'s list marketing in 2015.
In recent years, with preparation or the development of purification technique, technical staff develops a variety of more glucose sodium purifying process that relax. CN1402737 discloses the method that the more glucose sodium that relaxes is purified using dialysis, but uses a large amount of water when dialysis meeting, generates a large amount of useless Liquid is unfavorable for environmental protection, and yield is relatively low, is only capable of up to 34%.
WO2012025937 is reported prepares the easypro more glucose of purifying using silica gel chromatographic column and gel column Sephadex G-25 Sodium;WO2013037994 then develops a kind of adsorbent of novel solid supporting material, and using the adsorbent as chromatographic column Solid phase, to scheme to obtain the easypro more glucose sodium of high quality.
On the other hand, technical staff also develops purifies the more glucose sodium that relaxes in the way of solvent recrystallization, for example WO2014125501, CN104844732A, CN105273095A, refined solvent system used have:Methanol/water, ethanol/water or N, N- diformamides/water etc.;At the same time, CN105348412A report by easypro more glucose sodium salt switch to relax more glucammonium salts after, It recycles ethyl alcohol recrystallization to obtain the easypro more glucammonium salts of high-purity, is then switched to sodium-salt form again.
Although above-mentioned document has provided a variety of purifying thinkings, the more glucose sodium that relaxes is complicated and includes multiple chiralitys Center, especially gamma-cyclodextrin analogue is more, and all more or less existing defects of the above method cannot provide high-purity Easypro more glucose sodium, while meeting the needs that produce greatly of industry.Therefore, it is necessary to develop efficiently and be suitable for the Portugals industrial production Shu Geng Sugared sodium purifying method.
Invention content
The present invention provides a kind of purification process for the more glucose sodium that relaxes, this method includes:The more glucose sodium crude product that will relax loads In silica gel C18 on the chromatographic column of filler, to collect sample eluent after elution, more glucose sodium purity of relaxing in the sample eluent More than 99%, in embodiments can be 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9% or higher.
Wherein, the grain size of the silica gel C18 fillers is 5~60 μm, and specific surface area is in 100~300m2/ g, the polyphenyl second The grain size of alkene polymer is 20~100 μm, and specific surface area is in 500~1200m2/g。
In embodiments, with acetonitrile/water solution eluting silica gel C18 chromatographic columns, wherein ethane nitrile content is 10~30%, excellent 15~25% are selected as, can be 15,16,17,18,19,20,21,22,23,24,25%, more preferably 18~22%.In embodiment party In case, water and acetonitrile can be pumped to silica gel C18 chromatographic columns respectively by A, B pipeline and eluted.
It is adsorbed on silica gel C18 to reduce the more glucose sodium that relaxes, guarantee purification effect and yield, acetonitrile of the present invention/ In aqueous solvent also contain acid, the acid is known to those skilled in the art or confirmable, be selected from but not limited to formic acid, acetic acid, Trifluoroacetic acid, phosphoric acid, hydrochloric acid, preferably formic acid.Further, sour a concentration of 0.1 wherein in acetonitrile/water solvent~ 0.5wt.%, preferably 0.12~0.2wt.%, can be 0.12,0.13,0.14,0.15,0.16,0.17,0.18,0.19, 0.20wt.%.
On the other hand, technical staff also investigates eluent flow rate, finds eluent flow rate in the purification process Purification effect influences less, but the damage in order to avoid too fast flow velocity to silicagel column, while selected eluent flow rate also needs to examine Consider the size (internal diameter) of pillar.In embodiments, eluent flow rate control of the present invention is in 1L/min~1.5L/min (columns Sub- internal diameter 200mm), can be 1,1.1,1.2,1.3,1.4,1.5L/min;Preferably 1.1~1.3L/min, if pillar internal diameter Reduce, eluent flow rate is also required to accordingly reduce.
In more glucose sodium purification process of relaxing, technical staff has found that removal impurity E (retention time 22.28min) is entire The key point of purifying process determines the purifying max-thresholds of impurity E by lots of comparing experiments.When impurity E content is small in crude product In or be equal to 1%, impurity E can be down to 0.5% hereinafter, meeting bulk pharmaceutical chemicals quality standard by silica gel C18 chromatographic columns.Further , which is less than or equal to 0.6%, can be to 0.05% hereinafter, in embodiments by silica gel C18 column chromatographies Can be 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.1%, 0.09%, 0.08%, 0.07%, 0.06%, 0.05%, 0.04%, 0.03%, 0.02%, 0.01% or 0.
When impurity E content is the quality that cannot be satisfied bulk pharmaceutical chemicals by silica gel C18 column chromatographies more than 1% in crude product Standard impurities content is less than 0.1% requirement.In order to solve this technical problem, technical staff utilizes methacrylate ion Exchanger resin removes impurity E, i.e., purification process of the present invention also includes pure through methacrylate exchange resin elution The step of change.In embodiments, the step of being purified through methacrylate exchange resin elution can be C18 layers in silica gel Column purification is analysed before or after silica gel C18 column chromatographies.
In some embodiments, methacrylate ion exchange resin, gained eluent are eluted with sodium chloride solution In relax more glucose sodium purity be greater than or equal to 80%, wherein impurity E content be less than or equal to 0.1%, can be 0.1,0.09, 0.08,0.07,0.06,0.05,0.04,0.03,0.02,0.01% or 0;Further, relax more glucose sodium in the eluent Purity is greater than or equal to 90%, can be 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, preferably greatly In or equal to 95%.
Concentration of sodium chloride solution of the present invention be 0.1~1M (mol/L), can be 0.1,0.2,0.3,0.4,0.5, 0.6,0.7,0.8,0.9,1M, preferably 0.5M.
Methacrylate ion exchange resin of the present invention has the methacrylate backbone of surface hydrophilic characteristic, Resin rigidity is good, including Toyopearl GigaCap S-650M, Toyopearl GigaCap CM-650M, Toyopearl GigaCap Q-650M, Toyopearl GigaCap DEAE-650M, preferably Toyopearl GigaCap DEAE-650M (vehicle economy AE-650M).
In embodiments, in order to avoid inorganic impurity influences chromatographic effect and elution rate, the more glucose sodium crude product that relaxes needs Will be through membrane filtration, the filter sizes are 0.2~10 μm, preferably 0.3~5 μm, can be 0.3,0.35,0.4,0.45, 0.5、0.55、0.6、0.65、0.7、0.75、0.8、0.85、0.9、0.95、1、1.5、2、2.5、3、3.5、4、4.5、5μm。
Purification process of the present invention, this method include:
A) easypro more glucose sodium crude product is carried on methacrylate ion exchange resin, is eluted with sodium chloride solution pure Change, the methacrylate ion exchange resin preferably is selected from DEAE-650M;
B) it by eluent loading silica gel C18 chromatographic columns obtained by a) step, is eluted with acetonitrile/water solution, collects sample and wash De- liquid;
Wherein, ethane nitrile content be 10~30%, preferably 15~25%, can be 15,16,17,18,19,20,21,22, 23,24,25%, more preferably 18~22%.In embodiments, water and acetonitrile can be pumped to silica gel respectively by A, B pipeline C18 chromatographic columns are eluted.
Further, before b) step, eluent obtained by a) step is inorganic miscellaneous in solution to remove through membrane filtration Matter, the filter sizes be 0.2~10 μm, preferably 0.3~5 μm, can be 0.3,0.35,0.4,0.45,0.5,0.55, 0.6、0.65、0.7、0.75、0.8、0.85、0.9、0.95、1、1.5、2、2.5、3、3.5、4、4.5、5μm。
Further, by sample eluent it is concentrated obtain finished product relax more glucose sodium.
Silica gel C18 of the present invention is octadecyl silane filler, may be selected from but not limited to Hua Pu companies ACCHROM, Shanghai great You chromatographic techniques company DYPM952, DYB71306, DYB7129, the Unisil C18 of Na Wei companies, The welch Ultimate XB-C18 of Yue Xu companies, the preferably DYPM952 of great You chromatographies scientific & technical corporation.
Capto Q ImpRes and Capto SP ImpRes of the present invention are strong the moon of high-throughput purification of recombinant proteins matter Ion and strong cation exchanger, average particle size:40 μm, matrix:High flow capacity agarose, ligand:SP- sulfonate groups, Q- quaternary amines Base.
Solvent content (such as ethane nitrile content) of the present invention indicates acetonitrile percentage by volume in the solution;Wt% of the present invention (weight percent)=(quality of the quality+B of quality/A of B) × 100%.
Silica gel C18 or methacrylate ion exchange resin of the present invention are required for carrying out processing living before use, Its activating treatment method is well known to those skilled in the art or it was determined that for example the activation process of silica gel C18 may refer to Described in embodiment 2, the activation process of methacrylate ion exchange resin may refer to described in embodiment 4.
The mobile phase classification used of resin or silica gel C18 are eluted in the present invention, type of elution need according to respective attribute into Row selection, on judging whether resin or silica gel C18 can purify the more grape sodium that relaxes without influence.
The more glucose sodium crude product of the present invention that relaxes is prepared according to methods known in the art, is referred to WO2012025937 Method is prepared described in embodiment processed, and silica gel C18, Source 15Q and other resins of the present invention can pass through quotient Industry approach is bought.
Sample " purity " of the present invention or " content " are detected by HPLC to be obtained;Testing conditions are:Chromatographic column YMC ODS-AQ C18 (150 × 3.0mm, 3 μm);Detection wavelength 200nm;Using ammonium dibasic phosphate solution or acetonitrile as mobile phase.
The present invention is relaxed more glucose sodium retention time about 20.16min, impurity E retention time about 22.28min.It is of the present invention Relative retention time=(impurity peaks retention time)/(main peak retention time), impurity E relative retention time=1.1.
Specific implementation mode
The present invention, the range of but do not limit the invention in any way are further described below by way of example.
Embodiment 1:The preparation of easypro more glucose sodium crude product
3.50kg gamma-cyclodextrins are placed in vacuum drying chamber I, 95 DEG C of Zhen Kong Du of temperature≤- 0.08MPa dryings 10~ 12h is fitted into double-layer plastic bag, spare.
9.12kg triphenyl phosphorus and 35kg DMF are added in 100L reaction kettles, nitrogen protection, stirring and dissolving, be cooled to- 15 DEG C, the DMF solution (9.14kg is dissolved in 11kg DMF) of iodine is added dropwise, drop Bi Jixu stirs 0.5~1h, adds dry 3.00kg gamma-cyclodextrins, process control temp are no more than 0 DEG C, and heating is stirred to react.System cools down, and the methanol of sodium methoxide is added dropwise Solution (2.18kg sodium methoxides are dissolved in 8kg methanol) drips and finishes 0.5~1h of stirring, material solution is transferred in 50L plastic barrels.
It is pumped into 300kg purified waters into 500L reaction kettles II, the material solution in plastic barrel is instilled into reaction kettle II, drop finishes 0~15min is stirred, rejection filter is washed three times with purified water 30kg*3, and acetone 24kg*3 washings are three times.It is anti-that solid is transferred to 50L It answers in kettle III, 8kg industry DMF is added and dissolves solid, 45~55 DEG C of dropwise addition 20kg acetone are down to room temperature, are filtered naturally;Again Repeat dissolving punching analysis filter process twice.70 DEG C of vacuum degrees drying 23~for 24 hours intermediate γ-ICD, the amount of obtaining range 3.0~ 3.5kg, yield spectra 59.6~69.5%.
34kg chromatographically pure DMF are added into the reaction kettle IV of 200L, are added with stirring 0.76kgNaH, are cooled to -5 DEG C, drop Add the DMF solution (1.53kg is dissolved in 10kg chromatographically pures DMF) of 3- mercaptopropionic acids, drop, which finishes, is stirred at room temperature 1~2h.During room temperature is added dropwise The DMF solution (upper step gained γ-ICD are dissolved in 44kg chromatographically pures DMF) of mesosome γ-ICD, drop finishes, and is warming up to 65 DEG C of reactions.Drop Temperature is added dropwise 26kg purified waters and reaction is quenched, is stirred at room temperature, and filtering is purified water dissolution with 30kg, is transferred in 200L reaction kettles V, 86kg industry DMF punching analysis is added, filters, dry, must relax more glucose sodium crude product, the amount of obtaining range 1.2kg, yield 34.3%, purity 90.22%, impurity E content 0.77%.
Embodiment 2:
Filling prepares column:By 1.2kg silica gel C18 fillers (20 μm of grain sizes,) with after the wetting of 2.4L isopropanols, it is filled to system In the column tube of standby column, using dynamic axial compression so that filling pressure reaches 80~100Bar, uses 5~10 times of CV (cylinders Product) ethyl alcohol prepare column as mobile phase flushing with spare.
The more glucose sodium crude product that relaxes in 10g embodiments 1 is taken to be dissolved in 100ml purified waters, 0.45 μm of membrane filtration, to the system In continue to add water to 500ml, and adjust pH be acidity.
By the solution load sample to preparing on column, 0.15% aqueous formic acid and acetonitrile are pumped to chromatography respectively with A, B pipeline Column is eluted, and it is 21% to keep ethane nitrile content.The main peak eluted is divided into several sections of different fractions, merges qualified fraction, It is concentrated to give the more glucose sodium 3.7g that relaxes, yield 41%, purity 98.81%, impurity E content 0.21%.
Embodiment 3:
Column is prepared with spare according to 2 filling of embodiment
The 10g more glucose sodium crude products (purity 89.28%, impurity E content 0.60%) that relax are taken to be dissolved in 100ml purified waters, 0.45 μm of membrane filtration continues to add water to 500ml into the system, and it is acidity to adjust pH.
By the solution load sample to preparing on column, 0.15% aqueous formic acid and acetonitrile are pumped to chromatography respectively with A, B pipeline Column is eluted, and it is 21% to keep ethane nitrile content.The main peak eluted is divided into several sections of different fractions, merges qualified fraction, Be concentrated to give relax more glucose sodium 3.6g, yield 40%, purity 99.01%, impurity E content 0.05%.
Embodiment 4:
Load DEAE-650M chromatographic columns::2kg DEAE-650M resins are poured into glass column, with purified water, 0.5M hydrogen Sodium oxide molybdena, sodium chloride solution activate DEAE-650M resins with spare.
The easypro more glucose sodium crude products (purity 90.22%, impurity E content 0.77%) of about 1.2kg are dissolved in 30kg water, are stirred Uniform sample solution, loading to aforementioned DEAE chromatographic columns are eluted with 0.5M sodium chloride solutions, collect eluent respectively, are detected Merge afterwards and collect, purity 96.89%, yield 95%, impurity E is not detected.
Embodiment 5:
Load DEAE-650M chromatographic columns:2kg DEAE-650M resins are poured into glass column, with purified water, 0.5M hydrogen-oxygens Change sodium, sodium chloride solution activates DEAE-650M with spare.
The easypro more glucose sodium crude products (purity 92.21, impurity E content 1.5%) of about 1.2kg are dissolved in 30kg water, stirring is equal Even sample solution, loading to aforementioned DEAE-650M chromatographic columns are eluted with 0.5M sodium chloride solutions, collect eluent respectively, are received Collection is concentrated to give sample purity 96.89%, yield 93%, impurity E content 0.03% containing the more glucose sodium solution that relaxes.
Embodiment 6:
Load DEAE-650M chromatographic columns:2kg DEAE-650M resins are poured into glass column, with purified water, 0.5M hydrogen-oxygens Change sodium, sodium chloride solution activates DEAE-650M resins with spare.
The easypro more glucose sodium crude products (purity 92.21, impurity E content 0.92%) of about 1.2kg are dissolved in 30kg water, stirring is equal Even sample solution, loading to aforementioned DEAE-650M chromatographic columns are eluted with 0.5M sodium chloride solutions, are collected containing the more glucose sodium that relaxes Solution is concentrated to give sample purity 97.01%, yield 95%, impurity E content 0.02%.
Embodiment 7:
Filling prepares column:By 4.8~5.0kg silica gel C18 fillers (20 μm of grain sizes,) with after 10L ethanol wets, it is filled to It prepares in the column tube of column, using dynamic axial compression so that filling pressure reaches 80~100Bar, uses 5~10 times of CV (cylinders Product) ethyl alcohol prepare column as mobile phase flushing with spare.
Receiving liquid (purity 96.89%, impurity E is not detected) in embodiment 4 is adjusted with formic acid and obtains pH value to 3-4, and is added Enter acetonitrile so that feed liquid and the proportioning of acetonitrile reach 81:After 19,0.45 μm of organic membrane filters, by the solution, load sample arrives in four times It prepares on column, 0.15% aqueous formic acid and acetonitrile is pumped to chromatographic column respectively with A, B pipeline and eluted, keep ethane nitrile content It is 21%.The main peak eluted is divided into several sections of different fractions, merges qualified fraction, is concentrated to give the more glucose sodium that relaxes, purity 99.07%, yield 75%, impurity E is not detected.
Embodiment 8:
Source 15Q chromatographic columns (4.6*100mm) are loaded with spare
The easypro more glucose sodium crude products (purity 92.21%, impurity E content 1.5%) of about 40mg are dissolved in 30ml water, loading is extremely On ion exchange column, mobile phase A is used:Purified water, Mobile phase B:1M sodium-chloride water solutions carry out gradient elution, collect to contain and relax more Glucose sodium solution is concentrated to give sample purity 94.21%, impurity E content 0.86%.
Embodiment 9:
Capto Q ImpRes ion exchange columns (4.6*100mm) are loaded with spare
The easypro more glucose sodium crude products (purity 92.21%, impurity E content 1.5%) of about 40mg are dissolved in 300ml water, loading To ion exchange column, mobile phase A is used:Purified water, Mobile phase B:1M sodium-chloride water solutions carry out gradient elution, are examined through HPLC It surveys and collects containing the more glucose sodium solution that relaxes, be concentrated to give sample purity 95.21%, impurity E content 0.73%.
Embodiment 10:
001*7 cation exchange columns and D001 anion-exchange columns are loaded respectively with spare
The easypro more glucose sodium crude products (purity 93.21%, impurity E content 0.21%) of about 40mg are dissolved in 300ml water, then Aforementioned sample solution is passed through into 001*7 cation exchange columns and D001 anion-exchange columns successively, purifying water elution, warp is used in combination HPLC detections are collected containing the more glucose sodium solution that relaxes, and sample purity 94.09%, impurity E content 0.20% are concentrated to give.
Embodiment 11:
Sephadex G-25 gel columns (4.6*100mm) are loaded with spare
By about 50mg relax more glucose sodium crude product (purity 90.21, impurity E content 1.0%) be dissolved in 30ml water, loading to from It on sub- exchange column, is eluted with purified water, collects containing the more glucose sodium solution that relaxes, be concentrated to give sample purity 92.21%, impurity E Content 0.76%.
Embodiment 12:
Column is prepared with spare according to 2 filling of embodiment
The 10g more glucose sodium crude products (purity 90.03%, impurity E content 1.02%) that relax are taken to be dissolved in 100ml purified waters, 0.45 μm of membrane filtration continues to add water to 500ml into the system, and it is acidity to adjust pH.
By the solution load sample to preparing on column, 0.15% aqueous formic acid and acetonitrile are pumped to chromatography respectively with A, B pipeline Column is eluted, and it is 21% to keep ethane nitrile content.The main peak eluted is divided into several sections of different fractions, merges qualified fraction, It is concentrated to give more glucose sodium purity 98.92% of relaxing, impurity E content 0.5%.
Table 1:Embodiment related substances data summarization
Conclusion:
1, from the point of view of purifying crude data in embodiment 2,4-11, DEAE-650M resins and silica gel C18 have impurity E Impurity E can be down to 0.03% by good purification effect, especially DEAE-650M resins by 1.5%, the resin of other classifications or Impurity E can only be down to 0.7% or so by gel column, cannot meet more quality standard of the glucose sodium as bulk pharmaceutical chemicals of relaxing completely;
2, silica gel C18 has certain purification effect to impurity E in the more glucose sodium crude product that relaxes, and works as impurity E in crude product and be 1.02%, silica gel C18 cannot be down to 0.05% hereinafter, meeting the quality standard of bulk pharmaceutical chemicals.

Claims (10)

1. a kind of purification process for the more glucose sodium that relaxes, including:The more glucose sodium crude product that relaxes is carried on the chromatography that silica gel C18 is filler On column, sample eluent is collected after elution, more glucose sodium purity of relaxing in the preferably described sample eluent is more than 99%.
2. purification process according to claim 1, which is characterized in that acetonitrile/water solution eluting silica gel C18 chromatographic columns are used, Wherein ethane nitrile content is 10~30%, preferably 15~25%, more preferably 18~22%.
3. purification process according to claim 2, it is characterised in that also contain acid, the acid in the acetonitrile/water solution Selected from formic acid, acetic acid, trifluoroacetic acid, phosphoric acid, hydrochloric acid, preferably formic acid;A concentration of 0.1~0.5wt.% of the acid, preferably For 0.12~0.2wt.%.
4. purification process according to claim 1 or 2, it is characterised in that impurity E content in the more glucose sodium crude product that relaxes Less than or equal to 1%, preferably lower than or equal to 0.6%.
5. purification process according to claim 1 or 2, it is characterised in that the purification process further includes that easypro more glucose sodium is thick For product through membrane filtration step, the preferably described filter sizes are 0.2~10 μm, more preferably 0.3~5 μm.
6. purification process according to claim 1 or 2, it is characterised in that the eluent flow rate is 1~1.5L/min.
7. purification process according to claim 1 or 2, it is characterised in that the purification process further includes through methacrylic acid The step of ester exchange resin elution purifies, the methacrylate ion exchange resin preferably is selected from DEAE-650M;It is described More glucose sodium purity of relaxing in eluent is greater than or equal to 80%, and wherein impurity E content is less than or equal to 1%, preferably smaller than or waits In 0.6%.
8. purification process according to claim 7, which is characterized in that elute polymethyl acid ion with sodium chloride solution Exchanger resin chromatographs column, and the concentration of sodium chloride solution is 0.1~1M, preferably 0.5M.
9. purification process according to claim 7, it is characterised in that in the eluent relax more glucose sodium purity be more than or Equal to 90%, preferably greater than or equal to 95%.
10. according to claim 1~9 any one of them purification process, including:
A) easypro more glucose sodium crude product is carried on methacrylate ion exchange resin, is purified by flash with sodium chloride solution, institute It states methacrylate ion exchange resin and preferably is selected from DEAE-650M;
B) it by eluent loading silica gel C18 chromatographic columns obtained by a) step, is eluted with acetonitrile/water solution, collects sample eluent, Wherein ethane nitrile content is 10~30%, preferably 15~25%, more preferably 18~22%.
CN201810153493.0A 2017-02-22 2018-02-22 Method for purifying sugammadex sodium Active CN108456264B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710095613 2017-02-22
CN2017100956131 2017-02-22

Publications (2)

Publication Number Publication Date
CN108456264A true CN108456264A (en) 2018-08-28
CN108456264B CN108456264B (en) 2021-10-08

Family

ID=63216412

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810153493.0A Active CN108456264B (en) 2017-02-22 2018-02-22 Method for purifying sugammadex sodium

Country Status (1)

Country Link
CN (1) CN108456264B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109517093A (en) * 2018-12-29 2019-03-26 博瑞生物医药(苏州)股份有限公司 A kind of preparation method of the easypro more glucose sodium of high-purity
CN109517094A (en) * 2019-01-18 2019-03-26 苏州纳微科技股份有限公司 A kind of isolation and purification method for the more glucose that relaxes
CN109553702A (en) * 2018-12-29 2019-04-02 博瑞生物医药(苏州)股份有限公司 A kind of purification process for the more glucose sodium that relaxes
CN111548435A (en) * 2020-05-12 2020-08-18 杭州泽邦科技有限公司 Separation and purification method of sugammadex
CN111607019A (en) * 2020-06-23 2020-09-01 常州制药厂有限公司 Purification method of sugamonic acid
CN111632582A (en) * 2019-03-01 2020-09-08 月旭科技(上海)股份有限公司 Silica gel reverse phase chromatographic packing and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014125501A1 (en) * 2013-02-14 2014-08-21 Neuland Laboratories Limited An improved process for preparation of sugammadex sodium
CN105348412A (en) * 2014-08-22 2016-02-24 江苏恩华药业股份有限公司 Method for purifying sugammadex sodium
WO2016194001A1 (en) * 2015-05-29 2016-12-08 Alaparthi Lakshmi Prasad Processes for preparation of sugammadex and intermediates thereof
CN106565858A (en) * 2016-10-13 2017-04-19 王炳永 Purification method for sugammadex sodium

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014125501A1 (en) * 2013-02-14 2014-08-21 Neuland Laboratories Limited An improved process for preparation of sugammadex sodium
CN105348412A (en) * 2014-08-22 2016-02-24 江苏恩华药业股份有限公司 Method for purifying sugammadex sodium
WO2016194001A1 (en) * 2015-05-29 2016-12-08 Alaparthi Lakshmi Prasad Processes for preparation of sugammadex and intermediates thereof
CN106565858A (en) * 2016-10-13 2017-04-19 王炳永 Purification method for sugammadex sodium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨家亮等: "舒更葡糖钠的合成工艺研究", 《化学工程与装备》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109517093A (en) * 2018-12-29 2019-03-26 博瑞生物医药(苏州)股份有限公司 A kind of preparation method of the easypro more glucose sodium of high-purity
CN109553702A (en) * 2018-12-29 2019-04-02 博瑞生物医药(苏州)股份有限公司 A kind of purification process for the more glucose sodium that relaxes
CN109517093B (en) * 2018-12-29 2021-03-09 博瑞生物医药(苏州)股份有限公司 Preparation method of high-purity sugammadex sodium
CN109517094A (en) * 2019-01-18 2019-03-26 苏州纳微科技股份有限公司 A kind of isolation and purification method for the more glucose that relaxes
WO2020147421A1 (en) * 2019-01-18 2020-07-23 苏州纳微科技股份有限公司 Sugammadex isolation and purification method
CN111632582A (en) * 2019-03-01 2020-09-08 月旭科技(上海)股份有限公司 Silica gel reverse phase chromatographic packing and preparation method and application thereof
CN111632582B (en) * 2019-03-01 2023-02-28 月旭科技(上海)股份有限公司 Silica gel reverse phase chromatographic packing and preparation method and application thereof
CN111548435A (en) * 2020-05-12 2020-08-18 杭州泽邦科技有限公司 Separation and purification method of sugammadex
CN111548435B (en) * 2020-05-12 2022-03-18 杭州泽邦科技有限公司 Separation and purification method of sugammadex
CN111607019A (en) * 2020-06-23 2020-09-01 常州制药厂有限公司 Purification method of sugamonic acid
CN111607019B (en) * 2020-06-23 2021-03-02 常州制药厂有限公司 Purification method of sugamonic acid

Also Published As

Publication number Publication date
CN108456264B (en) 2021-10-08

Similar Documents

Publication Publication Date Title
CN108456264A (en) A kind of purification process for the more glucose sodium that relaxes
Andersson et al. Preparative chiral chromatographic resolution of enantiomers in drug discovery
US11667671B2 (en) Separation method
FI111072B (en) Procedure for the separation and purification of lactic acid
DE112015005181T5 (en) Mutant immunoglobulin-binding polypeptides
JP6900378B2 (en) Method for Purifying Polyether Block Copolymers
EP3048109A1 (en) Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom
EP2983804A1 (en) Ion exchange purification of mrna
CN109219613B (en) Separation method
WO2009135656A1 (en) A method for the purification of antibodies using displacement chromatography
Ötes et al. Feasibility of using continuous chromatography in downstream processing: Comparison of costs and product quality for a hybrid process vs. a conventional batch process
CN104513286B (en) A method of isolating and purifying Fei Da meter stars
Zhang et al. Hyperbranched anion exchangers prepared from thiol-ene modified polymeric substrates for suppressed ion chromatography
CN104672308A (en) Method for preparing vasopressin tannate
EP1638990B1 (en) Removal of lipopolysaccharides from protein- lipopolysaccharide complexes by nonflammable solvents
Chen et al. Efficient enantioseparation of phenylsuccinic acid enantiomers by aqueous two-phase system-based biphasic recognition chiral extraction: Phase behaviors and distribution experiments
CN108101959B (en) Method for preparing high-purity polypeptide or analogue thereof
Jing et al. A novel twin‐column continuous chromatography approach for separation and enrichment of monoclonal antibody charge variants
Hao et al. Rapid and high-capacity loading of IgG monoclonal antibodies by polymer brush and peptides functionalized microspheres
US20230124565A1 (en) Non-protein a purification method for adalimumab
Roberts et al. Protein adsorption and separation with monomodal and multimodal anion exchange chromatography resins. Part I. Multicomponent adsorption properties and frontal chromatography
Bzainia et al. A simple process to purify (E)-resveratrol from grape stems with a photo-molecularly imprinted sorbent
CN106496302B (en) Method for purifying protein by ion exchange chromatography
CN109988226A (en) A kind of purification process of oritavancin
CN115287282A (en) mRNA industrial separation and purification method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant